BIOMAT Database Logo BIOMAT Database Logo

[Daily serum complement (C'H50, beta 1C globulin) and erythrocyturia in active chronic glomerulonephritis during immunosuppressive therapy with azathioprine]. 1969

A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D001609 Beta-Globulins Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS. Beta(1)CA Globulin,Beta-Globulin,Beta Globulin,Beta Globulins

Related Publications

A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course.
January 1970, Nephron,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
Serum beta-1C globulin in glomerulonephritis and systemic lupus erythematosus.
August 1969, Annals of internal medicine,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
Beta-1C-globulin: metabolism in glomerulonephritis.
July 1966, Science (New York, N.Y.),
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
[Complement and beta-1C globulins in glomerulonephritis].
January 1967, Journal d'urologie et de nephrologie,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
[Serum beta-1AC globulin in glomerulonephritis during childhood].
November 1970, Ceskoslovenska pediatrie,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.
January 1967, Clinical and experimental immunology,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
[Serum complement (C'H50) in primary glomerular diseases].
January 1967, Bulletin de l'Academie nationale de medecine,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
ESTIMATION OF THE SERUM BETA-1C GLOBULIN CONCENTRATION: ITS RELATION TO THE SERUM HEMOLYTIC COMPLEMENT TITER.
May 1965, Pediatrics,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
Serum complement (beta 1C) in young children with atopic dermatitis.
July 1968, The Journal of allergy,
A Castellani, and P F Gambari, and G Riz, and G Mioni, and M Magalini, and T Barbui
[Liver tolerance to azathioprine in immunosuppressive therapy of chronic active liver diseases].
January 1974, Ceskoslovenska gastroenterologie a vyziva,
Copied contents to your clipboard!